AAIC 2025 Abstract
A Phase I Clinical Trial of AAV2‐BDNF Gene Therapy for Alzheimer's Disease: Findings
Trial in peopleInterventions
Abstract
Background: BDNF is a neurotrophic factor that prevents neuronal death, activates neuronal function, restores synapses and improves learning and memory in animal models of Alzheimer's disease.
